Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1

Author： Hourcade D.   Liszewski M.K.   Krych-Goldberg M.   Atkinson J.P.  

Publisher： Elsevier

ISSN： 0162-3109

Source： Immunopharmacology, Vol.49, Iss.1, 2000-08, pp. : 103-116

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A direct comparison of complement inhibitory capacities of the GPI- and transmembrane forms of mouse DAF to mouse Crry and human rsCR1

By Kraus D.   Guthridge J.M.   Marsh H.C.   Holers V.M.  

Immunopharmacology, Vol. 49, Iss. 1, 2000-08 ,pp. : 64-64

Elsevier

Access to resources Recommend Favorite

Impact of MCP-1 in Atherosclerosis

By  

Current Pharmaceutical Design, Vol. 20, Iss. 28, 2014-08 ,pp. : 4580-4588

Bentham Science Publishers

Access to resources Recommend Favorite

Functional Domains of Aquaporin-1: Keys to Physiology, and Targets for Drug Discovery

By  

Current Pharmaceutical Design, Vol. 13, Iss. 31, 2007-11 ,pp. : 3212-3221

Bentham Science Publishers

Access to resources Recommend Favorite

Functional domains of GABA A receptors

By Smith G.B.   Olsen R.W.  

Trends in Pharmacological Sciences, Vol. 16, Iss. 5, 1995-05 ,pp. : 162-168

Elsevier

Access to resources Recommend Favorite

Structural requirements for Decay Acclerating Activity (DAA) in complement receptor 1 (CR1; CD35)

By Krych-Goldberg M.   Hauhart R.   Blackmer D.   Atkinson J.P.  

Immunopharmacology, Vol. 49, Iss. 1, 2000-08 ,pp. : 62-62

Elsevier

Access to resources Recommend Favorite